Fujiwara H, Kato N, Shuntoh H, Tanaka C
Br J Pharmacol. 1987 Jun;91(2):287-97. doi: 10.1111/j.1476-5381.1987.tb10283.x.
The effect of dopamine receptor activation on electrically- or high K+ (30 mM)-evoked neurotransmitter release and rise in intracellular Ca2+ concentration was investigated using slices of guinea-pig neostriatum. A specific D2-dopamine receptor agonist, LY-171555 (a laevorotatory enantiomer of LY-141865: N-propyl tricyclic pyrazole) at 10(-6) M inhibited electrical stimulation- and high K+-evoked release of [3H]-acetylcholine ([3H]-ACh) to 47.7 +/- 6.0% and 54.1 +/- 5.0% of control, respectively. The maximal inhibition by LY-171555 at 10(-5) M was 54.8 +/- 5.1% reduction of the control. The half-maximal effective concentration (EC50) of LY-171555 for the inhibition of [3H]-ACh release was 2.3 X 10(-7) M. A specific D2-dopamine receptor antagonist, (-)-sulpiride (10(-7) M) reversed the inhibition of [3H]-ACh release induced by LY-171555. A specific D1-dopamine receptor agonist, SK&F 38393 (2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-benzazepine) (10(-5) M) had no effect on the release of [3H]-ACh. LY-171555 (10(-6) M) also inhibited the high K+-evoked endogenous glutamate release, by 47% of control. This inhibitory effect was reversed by (-)-sulpiride (10(-7) M). We used a fluorescent, highly selective Ca2+ indicator, 'quin 2' to measure intracellular free Ca2+ concentrations ([Ca2+]i). Electrical stimulation of slices preloaded with quin 2 led to an elevation of relative fluorescence intensity and this response was reduced by the removal of Ca2+ from the bathing medium. These results indicate that the enhanced elevation in fluorescence intensity in the quin 2-loaded slices reflects the increase of intracellular free Ca2+ concentration, [Ca2+]i. The mixed D1- and D2-receptor agonist, apomorphine and LY-171555 inhibited the increase of [Ca2+]i induced by electrical stimulation or high K+ medium, in a concentration-dependent manner, while SK&F 38393 did not affect the increase of [Ca2+]i. The maximal inhibitory effect of LY-171555 at 3 X 10(-5) M was 35 +/- 3% reduction in control values. The inhibitory effect of LY-171555 was antagonized by (-)-sulpiride (10(-7) M). There was a high correlation (r = 0.997, P less than 0.05) between the D 2-receptor-mediated inhibition of the stimulated rise of [Ca2+]i and [3H]-ACh release. When the slices were superfused with the Ca2+-free medium containing EGTA (10(-4) M) for 5 min, the rise in [Ca2+]i was markedly suppressed to 18.0% of control by LY-171555 (10(-6) M). These data indicate that activation of the D2-dopamine receptor suppresses the elevation of [Ca2+]i induced by depolarizing stimuli. This may be due to inhibition of mobilization of Ca2+ from the intracellullar store. We propose that the D2-receptor-mediated inhibition of transmitter release is probably due to a reduction in intracellular Ca2+ mobilization.
采用豚鼠新纹状体切片研究多巴胺受体激活对电刺激或高钾(30 mM)诱发的神经递质释放及细胞内钙离子浓度升高的影响。特异性D2-多巴胺受体激动剂LY-171555(LY-141865的左旋对映体:N-丙基三环吡唑),浓度为10^(-6) M时,分别将电刺激和高钾诱发的[3H]-乙酰胆碱([3H]-ACh)释放抑制至对照的47.7±6.0%和54.1±5.0%。LY-171555浓度为10^(-5) M时的最大抑制作用为对照值降低54.8±5.1%。LY-171555抑制[3H]-ACh释放的半数有效浓度(EC50)为2.3×10^(-7) M。特异性D2-多巴胺受体拮抗剂(-)-舒必利(10^(-7) M)可逆转LY-171555对[3H]-ACh释放的抑制作用。特异性D1-多巴胺受体激动剂SK&F 38393(2,3,4,5-四氢-7,8-二羟基-1-苯基-1H-苯并氮杂卓)(10^(-5) M)对[3H]-ACh释放无影响。LY-171555(10^(-6) M)也可将高钾诱发的内源性谷氨酸释放抑制至对照的47%。该抑制作用可被(-)-舒必利(10^(-7) M)逆转。我们使用荧光性、高选择性的钙离子指示剂“quin 2”来测量细胞内游离钙离子浓度([Ca2+]i)。对预先加载quin 2的切片进行电刺激会导致相对荧光强度升高,而去除浴液中的钙离子可使该反应减弱。这些结果表明,加载quin 2的切片中荧光强度增强的升高反映了细胞内游离钙离子浓度[Ca2+]i的增加。D1-和D2-受体混合激动剂阿扑吗啡和LY-171555以浓度依赖性方式抑制电刺激或高钾培养基诱导的[Ca2+]i升高,而SK&F 38393对[Ca2+]i升高无影响。LY-171555浓度为3×10^(-5) M时的最大抑制作用为对照值降低35±3%。LY-171555的抑制作用可被(-)-舒必利(10^(-7) M)拮抗。D2-受体介导的对刺激引起的[Ca2+]i升高的抑制作用与[3H]-ACh释放之间存在高度相关性(r = 0.997,P<0.05)。当切片在含EGTA(10^(-4) M)的无钙培养基中灌流5分钟时,LY-171555(10^(-6) M)可将[Ca2+]i升高显著抑制至对照的18.0%。这些数据表明,D2-多巴胺受体的激活可抑制去极化刺激诱导的[Ca2+]i升高。这可能是由于抑制了细胞内钙库中钙离子的动员。我们认为,D2-受体介导的递质释放抑制可能是由于细胞内钙离子动员减少所致。